ArticleBMC medical imaging2026
A two-stage deep learning model with segmentation-guided top-K slice selection for patient-level PAS prediction on MRI.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivePlacenta accreta spectrum (PAS) can cause severe obstetric complications, and accurate preoperative assessment is critical. However, heterogeneous MRI manifestations and the high cost of fine placental annotations limit deep learning applications. This study developed and validated a two-stage segmentation-guided MRI framework for automated placental localization, ROI selection, and patient-level PAS prediction.
methodsA total of 170 third-trimester placental MRI cases were included in the internal cohort, comprising 87 PAS and 83 non-PAS cases. Data were split at the patient level into training, internal validation, and internal test sets. An external validation cohort of 54 patients, including 36 PAS and 18 non-PAS cases, was additionally used. A 2D U-Net-based segmentation model first generated placental probability maps for ROI extraction. Selected ROIs were then classified using a ResNet-18 model, and slice-level probabilities were aggregated into patient-level predictions. The operating threshold was determined using the Youden index on the internal validation set.
resultsFor patient-level PAS classification, the internal validation set achieved an AUC of 0.85 (95% CI: 0.68-0.97), and the Youden-derived operating threshold was 0.61. In the held-out internal test set, the model achieved an AUC of 0.75 (95% CI: 0.53-0.92). In the external validation cohort of 54 patients, including 36 PAS and 18 non-PAS cases, the model achieved an AUC of 0.72 (95% CI: 0.54-0.87), sensitivity of 0.78 (95% CI: 0.62-0.88), specificity of 0.56 (95% CI: 0.34-0.75), and accuracy of 0.70 (95% CI: 0.57-0.81).
conclusionThis two-stage segmentation-guided MRI framework achieved reliable placental segmentation and moderate external performance for patient-level PAS prediction. The model may serve as an auxiliary screening and risk stratification tool, but further prospective multicenter validation and optimization are required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.